Correlation Between Lineage Cell and Cadrenal Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Lineage Cell and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lineage Cell and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lineage Cell Therapeutics and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on Lineage Cell and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lineage Cell with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lineage Cell and Cadrenal Therapeutics,.
Diversification Opportunities for Lineage Cell and Cadrenal Therapeutics,
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between Lineage and Cadrenal is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Lineage Cell Therapeutics and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and Lineage Cell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lineage Cell Therapeutics are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of Lineage Cell i.e., Lineage Cell and Cadrenal Therapeutics, go up and down completely randomly.
Pair Corralation between Lineage Cell and Cadrenal Therapeutics,
Given the investment horizon of 90 days Lineage Cell Therapeutics is expected to under-perform the Cadrenal Therapeutics,. In addition to that, Lineage Cell is 1.31 times more volatile than Cadrenal Therapeutics, Common. It trades about -0.15 of its total potential returns per unit of risk. Cadrenal Therapeutics, Common is currently generating about -0.03 per unit of volatility. If you would invest 1,509 in Cadrenal Therapeutics, Common on August 29, 2024 and sell it today you would lose (138.00) from holding Cadrenal Therapeutics, Common or give up 9.15% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lineage Cell Therapeutics vs. Cadrenal Therapeutics, Common
Performance |
| Timeline |
| Lineage Cell Therapeutics |
| Cadrenal Therapeutics, |
Lineage Cell and Cadrenal Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lineage Cell and Cadrenal Therapeutics,
The main advantage of trading using opposite Lineage Cell and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lineage Cell position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.| Lineage Cell vs. MAIA Biotechnology | Lineage Cell vs. Armata Pharmaceuticals | Lineage Cell vs. Portage Biotech | Lineage Cell vs. Cadrenal Therapeutics, Common |
| Cadrenal Therapeutics, vs. Eliem Therapeutics | Cadrenal Therapeutics, vs. Scpharmaceuticals | Cadrenal Therapeutics, vs. Milestone Pharmaceuticals | Cadrenal Therapeutics, vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |